Hey Stoops, may owe you a drink.Scoping study by year end sounds promising, will be interesting to see the product mix.Financing for the right product should not be an issue given the Japanese anxiety for near term CREO production.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025